期刊
ENDOCRINOLOGY
卷 159, 期 2, 页码 1062-1073出版社
ENDOCRINE SOC
DOI: 10.1210/en.2017-00685
关键词
-
资金
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK097544, DK099696, 1R01DK105183, DK107412]
Deficiencies in pancreatic beta-cell mass contribute to both type 1 and type 2 diabetes. We investigated the role of the glucose-regulated protein (GRP) 94, an endoplasmic reticulum protein abundantly expressed in the pancreatic acini and islets, in beta-cell development, survival, and function. We used a conditional knockout (KO) mouse in which the GRP94 gene, Hsp90b1, was specifically deleted in pancreatic and duodenal homeobox 1 (Pdx1)-expressing cells. These Hsp90b1 (flox/flox); Pdx1(Cre) KO mice exhibited pancreatic hypoplasia at embryonic day (E) 16.5 to E18.5 and had significantly reduced beta-cell mass at 4 weeks after birth. Further mechanistic studies showed that deletion of GRP94 reduced beta-cell proliferation with increased cell apoptosis in both Pdx1(+) endocrine progenitor cells and differentiated beta cells. Although Hsp90b1 (flox/flox); Pdx1(Cre) KO mice remained euglycemic at 8 weeks of age, they exhibited impaired glucose tolerance. In aggregate, these findings indicate that GRP94 is an essential regulator of pancreatic beta-cell development, mass, and function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据